BiotechTube
Home/Capacity Bio/Aaron Bergener
AB

Aaron Bergener

Chief Financial Officer

Capacity Bio

Therapeutic Areas

Mitochondrial DysfunctionAgingNeurodegenerative DiseasesMetabolic Diseases

Capacity Bio Pipeline

DrugIndicationPhase
Mitophagy AgonistUndisclosed (Mitochondrial Dysfunction)Pre-clinical

Leadership Team at Capacity Bio

KH
Ken Horne
Chief Executive Officer
AW
Amy Wang, PhD
Chief Operating Officer
KG
Kevin Gaffney, PhD
Chief Scientific Officer
KR
Kathleen Rodgers, PhD
Chief Medical Officer
OS
Orian Shirihai, MD, PhD
Scientific Advisor
View full Capacity Bio profile